Quantitative Liquid Chromatography-Tandem Mass Spectrometry
This test is New York DOH approved.
Effective February 19, 2013
||Total (amiodarone and metabolite): 0.5-2.0 µg/mL
||Greater than 3.0 µg/mL
Toxic concentrations may exacerbate arrhythmias, cause liver and lung toxicity, and thyroid dysfunction. The concentration of desmethylamiodarone, an active major metabolite, is also reported, but no therapeutic range is established. At steady-state, the metabolite concentration is similar to the amiodarone concentration.